David M. Mott, Director at Epizyme, Inc. (EPZM), sold 104,946 shares at $12.43 ($1.3M) on 2019-06-27, disclosed to the SEC on 2019-06-28.
Open-market sale of $1.3M EPZM by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $12.43 | 52,473 | $652K | 50.0% |
| 2 | $12.43 | 52,473 | $652K | 50.0% |
| Total | $12.43 avg | 104,946 | $1.3M | 100% |
| Filing → |
| ARDX | BUY | 2025-06-11 | $738K | — | Filing → |
| ARDX | BUY | 2025-05-19 | $329K | — | Filing → |
| ARDX | BUY | 2025-05-05 | $3.2M | — | Filing → |